Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-06-11
Item 5.07
This is a clear disclosure of shareholder vote results from Ares Management's June 8, 2026 annual meeting of stockholders. The filing reports voting outcomes for two proposals: (1) election of 11 directors to one-year terms, with detailed vote tallies for each nominee (FOR, AGAINST, ABSTAIN, BROKER NON-VOTES), and (2) ratification of Ernst & Young LLP as independent auditor. This is a textbook Item 5.07 disclosure and is material to investors as it confirms board composition and auditor ratification.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-11
Item 1.01
The filing discloses entry into a material definitive agreement—a Second Amendment to the Credit Agreement with Wells Fargo Bank extending the maturity date from June 25, 2027 to September 10, 2028. While this is a credit facility amendment rather than a traditional M&A transaction, it represents a material modification to the Company's financing arrangements that would affect a reasonable investor's assessment of liquidity and financial obligations. The extension of maturity by over a year is a substantive change to the capital structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-11
Item 5.07
This is a clear disclosure of shareholder vote results from LivaNova's 2026 Annual General Meeting held on June 10, 2026. The filing presents detailed voting tallies for all 10 resolutions considered, including director elections, say-on-pay, auditor ratification, and share authorization matters. This is a quintessential Item 5.07 disclosure and is material as it documents shareholder approval of key governance and compensation matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-11
Item 5.07
BeOne Medicines held its Annual Meeting on June 11, 2026, with shareholders voting on 20 proposals including director elections, compensation plan amendments (Fifth Amended and Restated 2016 Share Option and Incentive Plan and Sixth Amended and Restated 2018 Employee Share Purchase Plan), and capital allocation matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-11
Item 5.07
This 8-K Item 5.07 discloses the results of Coursera's 2026 Annual Meeting of Stockholders held on June 10, 2026, including voting outcomes on three proposals: election of Class II directors (McCarthy, Ng, Paterson), advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. The filing presents final vote tallies for each proposal, which is the core disclosure required under Item 5.07 for shareholder meeting results.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-11
Item 2.03
This Item 2.03 disclosure describes the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of New York. While the filing explicitly states "consolidated obligations issuance is material to the Bank," the disclosure is primarily informational and regulatory in nature—explaining the structure, joint and several liability framework, and reporting methodology for consolidated obligations rather than announcing a specific new debt issuance event. The absence of a Schedule A with specific issuance details and the emphasis on general policies and disclaimers suggest this is a routine periodic disclosure of the Bank's debt issuance program rather than a discrete material event triggering Item 2.03.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-11
Item 5.07
This is a classic Item 5.07 disclosure of shareholder meeting vote results. The filing reports the outcomes of four proposals voted on at the June 10, 2026 annual meeting: election of eight directors (approved), ratification of Grant Thornton LLP as auditors (approved), advisory vote on executive compensation (failed/not approved), and amendment to by-laws on quorum requirements (approved). The failure of Proposal 3 (say-on-pay) is material to investors as it signals shareholder dissatisfaction with executive compensation practices.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-11
Item 5.07
This is a clear disclosure of shareholder voting results from the June 10, 2026 annual meeting, reporting the election of five directors (John Swallow, Grant Brackebusch, Kevin Shiell, Rich Beaven, and Carolyn Turner) and ratification of Assure, CPA, LLC as independent auditor. The filing presents detailed vote tallies for each proposal, which is the hallmark of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-11
Item 5.07
This is a clear disclosure of shareholder voting results from Acushnet's June 8, 2026 Annual Meeting of Stockholders, covering three proposals: election of eight directors, non-binding advisory vote on executive compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. The filing presents final vote tallies for each proposal, which is the core content of Item 5.07 and constitutes a material event affecting investor understanding of corporate governance and board composition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-11
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from the June 5, 2026 annual meeting. The filing reports final voting tallies for four proposals: director elections (with the notable detail that two nominees—Lin and Taylor—failed to achieve majority votes but were retained by the Board following an administrative error explanation), auditor ratification, say-on-pay (which failed), and say-on-pay frequency. The say-on-pay rejection and the director election controversy (particularly the Board's decision to retain Lin and Taylor despite failing to win majority votes) are material to investors assessing governance and compensation practices.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-11
Item 7.01
HF Foods announced adoption of a "limited duration stockholder rights plan" (a poison pill), which is a material defensive measure that affects shareholder rights and capital structure. While not fitting neatly into the standard taxonomy categories (not M&A, not exec-related, not financial restatement), adoption of a rights plan is material to investors as it signals potential takeover defense and alters voting dynamics. This is disclosed under Item 7.01 (Regulation FD Disclosure) rather than a more specific Item, supporting classification as other_material.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-11
Item 5.02
The Board appointed three new independent directors—Robert Fotheringham, Zhenlong Jiao, and Henoc Muamba—on June 9, 2026, expanding the Board from three to six members. The new directors were assigned to lead key committees (Audit, Compensation, and Nominating and Corporate Governance), materially strengthening the company's governance structure.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-11
Item 8.01
On June 9, 2026, the Board adopted formal committee charters for the Audit, Compensation, and Nominating and Corporate Governance committees, appointed committee members, and adopted a Code of Ethics and insider trading policy. These governance framework and compliance actions materially enhance the company's corporate governance posture.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-06-11
Item 3.01
YHN Acquisition I Ltd received a Nasdaq deficiency notification on June 10, 2026, stating non-compliance with the minimum total holders requirement (400 holders) under Nasdaq Listing Rule 5450(a)(2). The company has 45 calendar days to submit a compliance plan and up to 180 days to evidence compliance, with the alternative of transferring to Nasdaq Capital Market. This is a classic delisting risk disclosure under Item 3.01, material to investors as it threatens the company's continued listing status.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-11
Item 5.02
The filing discloses the appointment of two new officers effective June 1, 2026: Andrew MacLeod as Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) and Robert Givens as Secretary. While the section also includes Michael Ssebugwawo's resignation from CFO and other officer roles, the principal disclosed action centers on filling those critical positions with new appointees. The appointments of a CFO and Secretary are material to investors' assessment of the company's governance and financial reporting structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-11
Item 1.01
Cardiff Lexington entered into a common stock purchase agreement with an institutional investor committing to purchase up to $25 million (expandable to $75 million) of common stock at a discount to market price (97% of VWAP), with the Company retaining discretion to direct purchases over 36 months. This is a classic "equity line of credit" or PIPE-like arrangement that creates substantial dilution risk to existing shareholders, particularly given the discount pricing mechanism and the Company's unilateral control over timing and amount of issuances.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-11
Item 3.02
The filing discloses an unregistered private placement of 285,768 shares of Series A Convertible Preferred Stock under Rule 506(b) of Regulation D, generating $2.84 million in gross proceeds during June 2–10, 2026. This is a classic dilutive issuance of equity securities exempt from registration, with 12.6 million shares of the preferred stock now outstanding. The convertible nature and substantial capital raise make this material to investors assessing ownership dilution and the company's capital structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-11
Item 5.07
This Item 5.07 disclosure reports the results of Carlyle Credit Solutions' 2026 Annual Meeting of Stockholders held on June 9, 2026, including voting outcomes for the election of two Class I directors (Linda Pace and William H. Wright II) and ratification of Ernst & Young LLP as independent auditor. The filing presents detailed vote tallies showing all proposals were approved by requisite margins, which is the core purpose of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-06-11
Item 5.02
Bryan D. Coy resigned as Executive Vice President and Chief Financial Officer on June 10, 2026. While the filing also discloses the appointment of Brett A. Correia as interim CFO, the primary disclosed action centers on Coy's departure from a senior executive role. The departure of a CFO is material to investors assessing management continuity and financial oversight. The severance arrangement (accelerated vesting of 21,327 restricted shares and up to six months of base salary) further underscores the significance of this executive departure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-11
Item 5.07
Item 5.07 discloses the results of Custom Truck One Source's June 11, 2026 annual stockholder meeting, including voting outcomes for the election of three Class A directors (Paul Bader, Mark D. Ein, and David Glatt) and ratification of Ernst & Young LLP as independent auditor. The tabulated vote counts and approval of all proposals are the core disclosure required under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-11
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from the 2026 Annual Meeting held on June 11, 2026. The filing reports final voting outcomes on three proposals: election of Class III directors (Proposal No. 1), advisory vote on named executive officer compensation (Proposal No. 2), and ratification of Deloitte & Touche LLP as independent auditor (Proposal No. 3), with detailed vote tallies certified by the Inspector of Elections. Shareholder voting outcomes are material to investors as they determine board composition and affirm governance decisions.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-06-11
Item 1.01
Bally's Intralot (59.44% owned by Bally's Corp) has entered into a definitive Cooperation Agreement to acquire all ordinary shares of Evoke PLC in an all-stock transaction valued at approximately £243.1 million. The acquisition is structured as a scheme of arrangement and is conditional on shareholder approvals and regulatory clearances. This is a material acquisition that would substantially affect the registrant's business and financial position.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-11
Item 5.07
This is a clear disclosure of shareholder voting results from an annual meeting of security holders, as required by Item 5.07. The filing reports results on four proposals: setting board size at seven directors, electing seven directors (with individual vote tallies for each nominee), a non-binding advisory vote on named executive officer compensation, and ratification of the independent auditor (WithumSmith+Brown, PC). The disclosure is material as it reflects shareholder approval of board composition and governance matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-11
Item 5.07
Cabaletta Bio held its Annual Meeting of Stockholders on June 9, 2026, at which stockholders voted on and approved six proposals: election of two Class I directors (Scott Brun, M.D. and Shawn Tomasello, MBA), ratification of Ernst & Young LLP as auditor, approval of a charter amendment increasing authorized common shares from 300 million to 600 million, an advisory vote on named executive officer compensation, and approval of an adjournment proposal.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-11
Item 7.01
CoreWeave announced a $3.5 billion senior notes offering intended for debt financing and general corporate purposes, including repayment of outstanding indebtedness. While this is a material capital-raising event affecting the registrant's financial structure, it does not fit cleanly into the taxonomy's more specific categories (ma_activity applies to acquisitions/dispositions, not debt issuances; dilutive_issuance applies to equity). The disclosure is material to investors as it signals significant leverage activity and refinancing strategy.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-11
Item 5.07
This is a clear disclosure of shareholder vote results from Remitly's June 10, 2026 Annual Meeting of Stockholders under Item 5.07. The filing reports voting outcomes on three proposals: election of directors (Bora Chung, Laurent Le Moal, and Nigel Morris), advisory approval of executive compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. All three proposals passed with substantial majorities, making this a material governance event that affects investor understanding of board composition and executive accountability.
View raw filing on EDGAR →
8-K
M&A activity
confidence 80%
filed 2026-06-11
Item 1.01
Porch Group's subsidiary Porticus entered into a Securities Purchase Agreement with the Porch Reciprocal Exchange to acquire 2,092,050 shares of Porch common stock for approximately $15 million on June 10, 2026. The transaction represents a material share repurchase affecting the company's capital structure, treasury stock position, and share count.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-11
Item 5.07
This is a clear disclosure of shareholder vote results from Instil Bio's 2026 Annual Meeting of Stockholders held on June 11, 2026. The filing reports voting outcomes for two proposals: (1) election of Class II directors George Matcham and Neil Gibson, and (2) ratification of RSM US LLP as the independent auditor. The disclosure includes vote tallies (votes for, against, withheld, and broker non-votes), which is the hallmark of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-11
Item 5.07
This is a clear disclosure of shareholder voting results from Immuneering's Annual Meeting of Stockholders held on June 11, 2026, covering the election of two Class II directors (Peter Feinberg and Laurie B. Keating) and ratification of RSM US LLP as independent auditor. The filing explicitly states the vote tallies and outcomes for each proposal, which is the core content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-11
Item 5.07
DoorDash held its annual meeting of stockholders on June 10, 2026. Shareholders voted on and approved three proposals: election of four Class III directors, ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation, all with substantial majorities.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-11
Item 2.02
The filing discloses quarterly financial results for the quarter ended March 28, 2026 via a press release furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition). This is a standard earnings release disclosure, which is material to investors assessing the registrant's operational and financial performance.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-11
Item 8.01
The Board authorized an additional $31.4 million share repurchase, bringing total authorized repurchases to $40 million. While share repurchase authorizations are routine capital allocation decisions, the magnitude ($31.4 million incremental authorization) and the disclosure in Item 8.01 suggest the company views this as material to investors' understanding of capital deployment strategy. However, this does not fit neatly into the more specific event categories (it is not a dilutive issuance, M&A activity, or executive compensation), so "other_material" is most appropriate.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-06-11
Item 1.01
Copley Acquisition Corp (a SPAC) entered into a Business Combination Agreement with Ignite Proteomics, LLC involving a two-step merger structure resulting in Ignite becoming a wholly-owned subsidiary of Pubco. The transaction contemplates $150 million in merger consideration paid in Pubco Common Stock plus a $4 million sponsor payment, with Pubco becoming a publicly traded company upon completion.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-11
Item 7.01
The filing discloses the appointment of Ms. Craig to the Board of Directors via press release issued on June 11, 2026. Board appointments are material events affecting the composition and governance of the registrant and would inform a reasonable investor's assessment of the company's leadership and oversight structure.
View raw filing on EDGAR →
8-K
Other material
confidence 45%
filed 2026-06-11
Item 1.01
Amendment No. 7 to the company's credit agreement added $50 million in incremental revolving loans and modified financial covenants, including replacement of a first lien leverage ratio with a total leverage ratio of 4.00:1.00. The covenant modification suggests potential financial stress or preparation for a material transaction, though no traditional M&A event is disclosed.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 92%
filed 2026-06-11
Item 8.01
The PIPC announced approximately $410 million in aggregate administrative fines against Coupang Corp. for data protection violations, including a previously disclosed November 2025 data incident and separate violations related to third-party advertising data collection. The company disclosed it will recognize these fines in Q2 2026 operating results and pursue judicial review in Seoul Administrative Court. This represents a material regulatory enforcement action with substantial financial consequences that would affect a reasonable investor's assessment of the company's financial condition and regulatory exposure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-11
Item 3.02
Xeris Biopharma is issuing shares of common stock in a private placement to noteholders exchanging approximately $23 million in principal amount of convertible notes under Section 4(a)(2) exemptions, representing a dilutive equity issuance that materially affects shareholder ownership.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-11
Item 8.01
Xeris Biopharma has entered into Exchange Agreements with noteholders, announced on June 11, 2026, involving material corporate transactions and exchange consideration that materially affect investors.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-11
Item 5.07
This Item 5.07 filing discloses the final results of the June 10, 2026 annual meeting of stockholders, including voting outcomes for three proposals: election of Class III directors (Aina E. Konold, Kristy Pipes, and Brian Ames), ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation. The disclosure of shareholder vote results at an annual meeting is a core shareholder_vote_results event, and the outcomes are material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-11
Item 2.02
McGraw Hill issued a press release on June 11, 2026 announcing financial results for the fiscal fourth quarter and fiscal year ended March 31, 2026.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-11
Item 8.01
The board approved a $50.0 million share repurchase plan on June 2, 2026, signaling management confidence in valuation and affecting capital deployment.
View raw filing on EDGAR →
8-K
M&A activity
confidence 45%
filed 2026-06-11
Item 1.01
Venture Global's wholly-owned subsidiary VGLNG completed a $2.25 billion senior secured notes offering and used proceeds to redeem existing debt, representing a material refinancing transaction affecting the company's capital structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-11
Item 5.07
This is a clear disclosure of shareholder voting results from the Company's Annual Meeting of Stockholders held on June 9, 2026. The filing reports the results of two proposals: (1) election of seven directors, with detailed vote tallies for each nominee, and (2) ratification of EY as independent auditor. This is a textbook Item 5.07 disclosure and is material as it reflects stockholder approval of board composition and auditor appointment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-10
Item 5.07
American Airlines Group held its 2026 Annual Meeting on June 10, 2026, with shareholders voting on seven proposals including election of all 12 director nominees (passed with substantial majorities), ratification of KPMG as independent auditor, advisory approval of executive compensation, and several governance proposals.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-06-10
Item 5.02
Shareholders approved an amended and restated 2023 Incentive Award Plan that increases shares reserved for issuance by 16.5 million shares and modifies tax withholding provisions, directly affecting equity grant structures for officers and directors.
View raw filing on EDGAR →
8-K
Exec departure
confidence 85%
filed 2026-06-10
Item 8.01
The filing discloses the death of William R. Berkley, the Company's founder and Executive Chairman, which is a material departure of a senior executive. While the section also mentions the appointment of W. Robert Berkley, Jr. as Chairman, the principal disclosed event centers on the founder's passing and the succession arrangement that follows, making this fundamentally an executive departure event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-10
Item 5.07
This is a clear disclosure of shareholder voting results from BRT Apartments Corp.'s annual meeting held on June 10, 2026. The filing presents detailed vote tallies for four proposals: election of directors (Carol Cicero, Frederic H. Gould, Gary Hurand, and Elie Weiss), advisory vote on executive compensation, ratification of Ernst & Young LLP as independent auditor, and approval of the 2026 Incentive Plan. All proposals were approved, making this a standard shareholder_vote_results disclosure under Item 5.07.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-06-10
Item 8.01
The Compensation Committee approved a $90,000 cash increase in annual compensation for Jeffrey D. Yowell, the Executive Chairman, effective June 1, 2026, bringing his total annual compensation to $340,000. This is a direct disclosure of a compensatory arrangement modification for a named executive officer, which falls squarely within the exec_compensation category. The materiality is supported by the magnitude of the increase and the fact that it was formally approved by the Committee.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-06-10
Item 8.01
The filing announces Kewaunee Scientific's plan to release fourth quarter and fiscal year 2026 financial results on June 23, 2026. Although the actual earnings results are not yet disclosed in this 8-K, the announcement of an imminent earnings release for a full fiscal year is a material event that would affect investor expectations and trading. The press release is furnished as Exhibit 99.1, consistent with earnings announcement disclosures.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-10
Item 2.02
Oxford Industries issued a press release on June 10, 2026 announcing financial results for fiscal 2026 first quarter ended May 2, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a standard quarterly earnings release disclosure, which is material to investors assessing the company's operational performance and financial condition.
View raw filing on EDGAR →